The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Allison W. Kurian, M.D., M.Sc.
Medical oncologist, Breast specialist, Cancer geneticist
Practice Areas
Professional Education
- M.Sc., Stanford University, Epidemiology (2006)
- Board Certification: Medical Oncology, American Board of Internal Medicine (2005)
- Fellowship: Stanford University School of Medicine (2005) CA
- Residency: Massachusetts General Hospital (2002) MA
- Internship: Massachusetts General Hospital (2000) MA
- Medical Education: Harvard Medical School (1999) MA
- B.A., Honors, Stanford University, Human Biology (1995)
Honors & Awards
- Merit Award, American Society of Clinical Oncology (2004)
- Fellowship Award, California Breast Cancer Research Program (2005)
- Fellowship Award, Cancer Research and Prevention Foundation (2005)
- Young Investigator Award, American Society of Clinical Oncology (2005)
- BIRCWH K12 Scholar Award, National Institutes of Health (2006)
- Cornelius L. Hopper Research Abstract Award, California Breast Cancer Research Program (2007)
- Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
- Jan Weimer Faculty Chair for Breast Oncology, Stanford University Cancer Institute (2008)
- Translational Research Award, California Breast Cancer Research Program (2010)
- New Clinical Investigator Award, Stanford University Cancer Institute (2011)
- Top 12 publications funded by the Epidemiology and Genomics Research Program, National Cancer Institute (2011)
- Suzanne Pride Bryan Award for Breast Cancer Research, Stanford University Cancer Institute (2013)
- Oncology Division Teaching Award, Stanford University School of Medicine (2014)
Administrative Appointments
- Associate Director, Stanford Clinical Cancer Genomics Program (2007 - Present)
- Career Development Subcommittee, American Society of Clinical Oncology (2008 - 2011)
- Program Committee, Professional Development, American Society of Clinical Oncology (2008 - 2011)
- Panel on Clinical Guidelines Development for Genetic/ Familial Risk: Breast and Ovarian Cancer, National Comprehensive Cancer Network (2009 - Present)
- Board of Directors, Santa Clara County, American Cancer Society (2011 - Present)
- Scientific Program Committee, Genetic and Molecular Epidemiology, American Association for Cancer Research (2011 - 2012)
- Scientific Program Committee, Quality Care Symposium, American Society of Clinical Oncology (2012 - 2015)
- Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
- Advisory Committee, California HealthCare Foundation (2012 - Present)
- Director, Stanford Women's Clinical Cancer Genetics Program (2012 - Present)
- Panel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive Cancer Network (2013 - Present)
- Director, Cancer Education Seminar, Stanford Division of Oncology (2013 - Present)
- Track Leader, Cancer Prevention and Epidemiology, Scientific Program Committee, American Society of Clinical Oncology (2013 - 2014)
- Associate Member, Canary Center at Stanford for Cancer Early Detection (2014 - Present)
- Oncology Consultant, Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling Network (CISNET), National Cancer Institute (2014 - Present)
- Co-Investigator, Prospective Registry of MultiPlex Testing (PROMPT) Study (2014 - Present)
- Primary Medical Oncologist Investigator, Cancer Surveillance and Outcomes Research Team (CanSORT), University of Michigan School of Medicine (2014 - Present)
- Board of Directors Member, Facing Our Risk of Cancer Empowered (FORCE) (2015 - Present)
- External Advisory Board Member, Cancer Genomics Program, Princess Margaret Hospital Cancer Centre (2015 - Present)
- Editorial Board; Special Editor for Hereditary Cancer Syndromes, Cancer.Net, American Society of Clinical Oncology (2015 - Present)
Publications
-
Multigene Panel Testing in Oncology Practice: How Should We Respond?
Kurian, A. W., & Ford, J. M. (2015). Multigene Panel Testing in Oncology Practice: How Should We Respond?. JAMA oncology, 1(3), 277-278. -
Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact.
Kurian, A. W., & Friese, C. R. (2015). Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact. JAMA oncology. -
Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
Katz, S. J., Kurian, A. W., & Morrow, M. (2015). Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations. JAMA. -
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. Hm., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014). Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA-the journal of the American Medical Association, 312(9), 902-914.
-
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., & Ford, J. M. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. JOURNAL OF CLINICAL ONCOLOGY, 32(19), 2001-2009.
-
Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.
Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., & Das, A. K. (2014). Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer, 120(1), 103-111.
-
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007
Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. Hm., Leung, R. W., Shema, S. J., & Gomez, S. L. (2013). Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. BREAST CANCER RESEARCH AND TREATMENT, 137(1), 247-260.
-
Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers
Kurian, A. W., Munoz, D. F., Rust, P., Schackmann, E. A., Smith, M., & Plevritis, S. K. (2012). Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 30(5), 497-506.
-
Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research.
Weber, S. C., Seto, T., Olson, C., Kenkare, P., Kurian, A. W., & Das, A. K. (2012). Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2012, 970-978.
-
Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., & Whittemore, A. S. (2011). Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry. JOURNAL OF CLINICAL ONCOLOGY, 29(34), 4505-4509.
-
Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
Kurian, A. W., Sigal, B. M., & Plevritis, S. K. (2010). Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 28(2), 222-231.
-
Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups
Kurian, A. W., Fish, K., Shema, S. J., & Clarke, C. A. (2010). Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. BREAST CANCER RESEARCH, 12(6).
-
Second Primary Breast Cancer Occurrence According to Hormone Receptor Status
Kurian, A. W., McClure, L. A., John, E. M., Horn-Ross, P. L., Ford, J. M., & Clarke, C. A. (2009). Second Primary Breast Cancer Occurrence According to Hormone Receptor Status. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 101(15), 1058-1065.
-
Performance of BRCA1/2 mutation prediction models in Asian Americans
Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., & Ford, J. M. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. JOURNAL OF CLINICAL ONCOLOGY, 26(29), 4752-4758.
-
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer
Kurian, A. W., Newton Thompson, R., Gaw, A. F., Arai, S., Ortiz, R., & Garber, A. M. (2007). A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 25(6), 634-641.
-
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., & Garber, A. M. (2006). Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295(20), 2374-2384.
-
Histologic types of epithelial ovarian cancer: have they different risk factors?
Kurian, A. W., Balise, R. R., McGuire, V., & Whittemore, A. S. (2005). Histologic types of epithelial ovarian cancer: have they different risk factors?. GYNECOLOGIC ONCOLOGY, 96(2), 520-530.
-
Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer.
Shariff-Marco, S., Yang, J., John, E. M., Kurian, A. W., Cheng, I., & Gomez, S. L. (2015). Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. Journal of community health, 40(6), 1287-1299.
-
Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects
Mitani, A. A., Kurian, A. W., Das, A. K., & Desai, M. (2015). Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects. STATISTICAL METHODOLOGY, 27, 82-99.
-
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., & Ellisen, L. W. (2015). Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA oncology.
-
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients
Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., & Ellisen, L. W. (2015). A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. JOURNAL OF MOLECULAR DIAGNOSTICS, 17(5), 533-544.
-
Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
Afghahi, A., Forgo, E., Mitani, A. A., Desai, M., Varma, S., & West, R. B. (2015). Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. BREAST CANCER RESEARCH, 17.
-
Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium
Cheng, I., Shariff-Marco, S., Koo, J., Monroe, K. R., Yang, J., & Keegan, T. Hm. (2015). Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(8), 1282-1290.
-
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study
Tao, L., Gomez, S. L., Keegan, T. Hm., Kurian, A. W., & Clarke, C. A. (2015). Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(7), 1039-1045.
-
Breast Cancer Risk Reduction, Version 2.2015
Bevers, T. B., Ward, J. H., Arun, B. K., Colditz, G. A., Cowan, K. H., & Kumar, R. (2015). Breast Cancer Risk Reduction, Version 2.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(7), 880-915.
-
History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium
Lu, Y., John, E. M., Sullivan-Halley, J., Vigen, C., Gomez, S. L., & Bernstein, L. (2015). History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 181(12), 944-955.
-
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
Telli, M. L., Jensen, K. C., Vinayak, S., Kurian, A. W., Lipson, J. A., & Ford, J. M. (2015). Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105. JOURNAL OF CLINICAL ONCOLOGY, 33(17), 1895-U57.
-
Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., & Hawley, S. T. (2015). Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Journal of clinical oncology , 33(14), 1584-1591.
-
Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System
Keegan, T. Hm., Kurian, A. W., Gali, K., Tao, L., Lichtensztajn, D. Y., & Gomez, S. L. (2015). Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System. AMERICAN JOURNAL OF PUBLIC HEALTH, 105(5), 938-946.
-
How can we best respect patient autonomy in breast cancer treatment decisions?
Martinez, K. A., Kurian, A. W., Hawley, S. T., & Jagsi, R. How can we best respect patient autonomy in breast cancer treatment decisions?. Breast cancer management, 4(1), 53-64.
-
Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment
Kurian, A. W., Kingham, K. E., & Ford, J. M. (2015). Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 27(1), 23-33.
-
Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC)
Wu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., & Vigen, C. (2015). Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC). CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(2), 361-368.
-
Linking electronic health records to better understand breast cancer patient pathways within and between two health systems
Thompson, C. A., Kurian, A. W., & Luft, H. S. (2015). Linking electronic health records to better understand breast cancer patient pathways within and between two health systems. eGEMs (Generating Evidence & Methods to improve patient outcomes), 3(1).
-
Reply to S.M. Sorscher and A.B. Hafeez Bhatti.
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., & Hawley, S. T. (2015). Reply to S.M. Sorscher and A.B. Hafeez Bhatti. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
-
Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.
Kwong, A., Shin, V. Y., Ho, J. C., Kang, E., Nakamura, S., & Kim, S. W. (2015). Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. Journal of medical genetics.
-
Multiple-Gene Panels and the Future of Genetic Testing
Kurian, A. W., & Ford, J. M. (2015). Multiple-Gene Panels and the Future of Genetic Testing. Current Breast Cancer Reports.
-
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014
Daly, M. B., Pilarski, R., Axilbund, J. E., Buys, S. S., Crawford, B., & Kumar, R. (2014). Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(9), 1326-1338.
-
Response.
Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., & Ikeda, D. M. (2014). Response. Radiology, 271(3), 927-928.
-
Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health
Halley, M. C., May, S. G., Rendle, K. As., Frosch, D. L., & Kurian, A. W. (2014). Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health. CULTURE HEALTH & SEXUALITY, 16(9), 1169-1180.
-
Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium
Kwan, M. L., John, E. M., Caan, B. J., Lee, V. S., Bernstein, L., & Wu, A. H. (2014). Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 179(1), 95-111.
-
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival
Wu, A. H., Gomez, S. L., Vigen, C., Kwan, M. L., Keegan, T. Hm., & Sposto, R. (2013). The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. CANCER CAUSES & CONTROL, 24(10), 1821-1836.
-
A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer
DeRouen, M. C., Gomez, S. L., Press, D. J., Tao, L., Kurian, A. W., & Keegan, T. Hm. (2013). A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2(3), 95-103.
-
A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management
de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2013). A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(5), 512-517.
-
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers
Schackmann, E. A., Munoz, D. F., Mills, M. A., Plevritis, S. K., & Kurian, A. W. (2013). Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. FAMILIAL CANCER, 12(1), 65-73.
-
The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation
Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., & Ikeda, D. M. (2013). The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation. RADIOLOGY.
-
Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium
Kurian, A. W., & Edge, S. B. (2013). Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium. JOURNAL OF ONCOLOGY PRACTICE, 9(3).
-
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk
Vinayak, S., Schwartz, E. J., Jensen, K., Lipson, J., Alli, B., & Kurian, A. W. (2013). A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. BREAST CANCER RESEARCH AND TREATMENT, electronic publication ahead of print, October 30.
-
Impact of breast cancer subtypes on three-year survival among adolescent and young adult women
Keegan, T. Hm., Press, D. J., Tao, L., DeRouen, M. C., Kurian, A. W., & Gomez, S. L. (2013). Impact of breast cancer subtypes on three-year survival among adolescent and young adult women. BREAST CANCER RESEARCH, 15(5).
-
Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
Kwong, A., Ng, E. Ko., Law, F. Bf., Wong, H. N., Wa, A., & Ma, E. Sk. (2012). Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 136(3), 931-933.
-
Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis
Kwong, A., Ng, E. K. O., Wong, C. L. P., Law, F. B. F., Au, T., & Ma, E. S. K. (2012). Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis. PLOS ONE, 7(9).
-
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations
de Bruin, M. A., Kwong, A., Goldstein, B. A., Lipson, J. A., Ikeda, D. M., & Kurian, A. W. (2012). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. FAMILIAL CANCER, 11(3), 429-439.
-
A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers
Sigal, B. M., Munoz, D. F., Kurian, A. W., & Plevritis, S. K. (2012). A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(7), 1066-1077.
-
Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover
Clarke, C. A., Keegan, T. Hm., Yang, J., Press, D. J., Kurian, A. W., & Lacey, J. V. (2012). Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(14), 1094-1101.
-
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Powell, A. A., Talasaz, Aa. H., Zhang, H., Coram, M. A., Reddy, A., & Jeffrey, S. S. (2012). Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. PLOS ONE, 7(5).
-
Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California
Gomez, S. L., Press, D. J., Lichtensztajn, D., Keegan, T. Hm., Shema, S. J., & Kurian, A. W. (2012). Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(5), 821-834.
-
Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort
Kwong, A., Wong, C. Hn., Suen, D. Tk., Co, M., Kurian, A. W., & Ford, J. M. (2012). Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort. WORLD JOURNAL OF SURGERY, 36(4), 702-713.
-
In reply to "Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies" by Evans et al
Kurian, A. W., & Whittemore, A. S. (2012). In reply to "Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies" by Evans et al. JOURNAL OF CLINICAL ONCOLOGY, 30.
-
Genetic Polymorphisms as Predictors of Breast Cancer Risk
de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2012). Genetic Polymorphisms as Predictors of Breast Cancer Risk. CURRENT BREAST CANCER REPORTS.
-
Occurrence of breast cancer subtypes in adolescent and young adult women
Keegan, T. Hm., DeRouen, M. C., Press, D. J., Kurian, A. W., & Clarke, C. A. (2012). Occurrence of breast cancer subtypes in adolescent and young adult women. BREAST CANCER RESEARCH, 14(2).
-
A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
Chen, Y., Kingham, K., Ford, J. M., Rosing, J., Van Dam, J., & Norton, J. A. (2011). A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer. ANNALS OF SURGICAL ONCOLOGY, 18(9), 2594-2598.
-
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
Telli, M. L., Chang, E. T., Kurian, A. W., Keegan, T. Hm., McClure, L. A., & Gomez, S. L. (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. BREAST CANCER RESEARCH AND TREATMENT, 127(2), 471-478.
-
Hereditary cancer: counseling women at risk
Lebensohn, A. P., Kingham, K. E., Chun, N. M., & Kurian, A. W. (2011). Hereditary cancer: counseling women at risk. CONTEMPORARY OBSTETRICS AND GYNECOLOGY, 56(4).
-
High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients
Kwong, A., Ng, E. Ko., Law, F. Bf., Wong, L. P., To, M. Y., & Ma, E. Sk. (2010). High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 122(2), 605-607.
-
Genetic/familial high-risk assessment: breast and ovarian.
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., & Weitzel, J. N. (2010). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network , 8(5), 562-594.
-
Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California
Gomez, S. L., Lichtensztajn, D., Kurian, A. W., Telli, M. L., Chang, E. T., & Clarke, C. A. (2010). Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California. JOURNAL OF CLINICAL ONCOLOGY, 28(10), E155-E157.
-
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Kurian, A. W. (2010). BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 22(1), 72-78.
-
Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry
Kurian, A. W., Gong, G. D., John, E. M., Miron, A., Felberg, A., & Whittemore, A. S. (2009). Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(4), 1084-1091.
-
In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al
Kurian, A. W., Whittemore, A. S., & Ford, J. M. (2009). In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al. JOURNAL OF CLINICAL ONCOLOGY, 27.
-
The Decline in Breast Cancer Incidence: Real or Imaginary?
Kurian, A. W., Clarke, C. A., & Carlson, R. W. (2009). The Decline in Breast Cancer Incidence: Real or Imaginary?. CURRENT ONCOLOGY REPORTS, 11(1), 21-28.
-
Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.
Vinayak, S., & Kurian, A. W. (2009). Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. Current breast cancer reports, 1(3), 148-156.
-
Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers
Staton, A. D., Kurian, A. W., Cobb, K., Mills, M. A., & Ford, J. M. (2008). Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. FAMILIAL CANCER, 7(2), 179-186.
-
Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology
Kurian, A. W., Hartman, A.-R., Mills, M. A., Logan, L. J., Sawyer, A. M., & Daniel, B. L. (2008). Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology. BREAST JOURNAL, 14(2), 211-214.
-
A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature
Ghataorhe, P., Kurian, A. W., Pickart, A., Trapane, P., Norton, J. A., & Ford, J. M. (2007). A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature. CANCER GENETICS AND CYTOGENETICS, 179(2), 89-92.
-
CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer
Norton, J. A., Ham, C. M., Van Dam, J., Jeffrey, R. B., Longacre, T. A., & Ford, J. M. (2007). CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer. ANNALS OF SURGERY, 245(6), 873-879.
-
Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage
Ghanouni, P., Kurian, A. W., Margolis, D., Hartman, A.-R., Mills, M. A., & Daniel, B. L. (2007). Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage. BREAST JOURNAL, 13(3), 281-286.
-
Biomedical terahertz imaging with a quantum cascade laser
Kim, S. M., Hatami, F., Harris, J. S., Kurian, A. W., Ford, J., & Harris, G. (2006). Biomedical terahertz imaging with a quantum cascade laser. APPLIED PHYSICS LETTERS, 88(15).
-
Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage
Kurian, A. W., Hartman, A. R., Mills, M. A., Ford, J. M., Daniel, B. L., & Plevritis, S. K. (2005). Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. HEALTH EXPECTATIONS, 8(3), 221-233.
-
Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk
Kurian, A. W., Mills, M. A., Jaffee, M., Sigal, B. M., Chun, N. M., & Hartman, A. R. (2005). Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 14(5), 1082-1089.
-
Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma
Hartman, A. R., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., & Plevritis, S. K. (2004). Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. CANCER, 100(3), 479-489.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Aug 2015
Excellent.
SHC Patient, Aug 2015
I love Dr. Kurian.
SHC Patient, Jul 2015
The Best Provider
SHC Patient, Jul 2015
Amazing!
SHC Patient, Jun 2015
Dr. Kurian and her staff are awesome! I have total confidence (while in her care) that I am receiving the best possible treatment.
SHC Patient, Jun 2015
This was a first time by herself checked for me. She was very nice but couldn't talk much.
SHC Patient, Feb 2015
Did not like the nurse at all, but dr. is excellent.
SHC Patient, Jan 2015
Very impressed.
SHC Patient, Dec 2014
Excellent dr. & very caring.
SHC Patient, Dec 2014
Dr. Kurian & Miranda Kramer, NP are excellent and give outstanding care.
SHC Patient, Nov 2014
Dr. Kurian is a brilliant, caring doctor - but her availability is limited. She also has a formal East Coast style that might not appeal to everyone. I value Dr. Kurian greatly - but for oncologists there must be a personality match.
SHC Patient, Aug 2014
Excellent, empathetic & compassionate staff all around.
SHC Patient, Jun 2014
Dr. Kurian is wonderful!
SHC Patient, May 2014
Dr. Kurian and the genetic counselor were excellent! VERY GOOD care. Thank YOU!
SHC Patient, Mar 2014
Another doctor accompanied Dr. Kurian, but she was not introduced.
SHC Patient, Mar 2014
Dr. Kurlan was thorough, cited research, explained details, answered myriad questions. Was credible & kind and awesome.
SHC Patient, Aug 2015
Excellent.
SHC Patient, Aug 2015
I love Dr. Kurian.
SHC Patient, Jul 2015
The Best Provider
SHC Patient, Jul 2015
Amazing!
SHC Patient, Jun 2015
Dr. Kurian and her staff are awesome! I have total confidence (while in her care) that I am receiving the best possible treatment.
SHC Patient, Jun 2015
This was a first time by herself checked for me. She was very nice but couldn't talk much.
SHC Patient, Feb 2015
Did not like the nurse at all, but dr. is excellent.
SHC Patient, Jan 2015
Very impressed.
SHC Patient, Dec 2014
Excellent dr. & very caring.
SHC Patient, Dec 2014
Dr. Kurian & Miranda Kramer, NP are excellent and give outstanding care.
SHC Patient, Nov 2014
Dr. Kurian is a brilliant, caring doctor - but her availability is limited. She also has a formal East Coast style that might not appeal to everyone. I value Dr. Kurian greatly - but for oncologists there must be a personality match.
SHC Patient, Aug 2014
Excellent, empathetic & compassionate staff all around.
View All 16 Patient Comments »